<---Back
to Flow Cyto Home
<---
Back to Protocols
FLUORESCENT DETECTION
OF NON-VIABLE CELLS IN FIXED CELL PREPARATIONS
T. J. Fetterhoff, S.P.
Holland, and K. J. Wile, Boehringer Mannheim Corp., Research &
Development, Indianapolis, IN, USA. Cytometry Supplement 6: 27
(1993).
Cell lysis and or fixation
have become common practice in flow cytometric sample preparation.
A procedure has been developed that allows detection of cells
that were non-viable prior to cell fixation. This technique overcomes
the problems of artefacts caused from non-specific uptake of antibodies
by non-viable cells at the time of staining. 7-Amino-Actinomycin
D (7-AAD) is used to identify non- viable cells during immunostaining.
Following several washes, cells are lysed or fixed in solutions
that contain molar excess of the non-fluorescent Actinomycin D
(AD). AD competes with 7-AAD for binding sites to ds DNA and inhibits
further uptake by 7-AAD. Furthermore, 7AAD exhibits spectral characteristics
enabling fluorescence separation from FITC as well as PE. This
procedure allows cell fixation to inactivate infectious agents
and eliminates artefactual staining by non-viable cells. © 1993
Wiley-Liss, Inc.
Materials
7-Amino-Actinomycin D (Calbiochem Cat
#129935)
Actinomycin D (Alexis Biochemicals Cat
# ALX-380-009)
Phospahte Buffered Saline (PBS)
Para-formaldehyde, (From 2% Stock)
Protocol
- Resuspend labeled
cells in 100 ml PBS that contains
20 mg 7-AAD; incubate for 30 minutes
at 4°C.
- Centrifuge and
resuspend pellet in 100 ml of PBS
that contains 0.5% para-formaldehyde and 50 mg
actinomycin-D; incubate 30 minutes at 4°C
- Centrifuge and
resuspend pellet in PBS; hold at 4°C in the dark.
References:
- Schmid I, Uittenbogaart
CH, Krall WJ, Braun J and Giorgi JV. Dead cell discrimination
with 7-amino-actinomycin D in combination with dual color immunofluorescence
in single laser flow cytometry. Cytometry 13:204-208, 1992.
- Fetterhoff TJ, Holland
SP, and Wile, KJ. Fluorescent detection of non-viable cells
in fixed cell preparations. Cytometry 14 (Suppl. 6):27, 1993.
<---Back
to Flow Cyto Home
<---
Back to Protocols
Dennis J.
Young, UCSD Cancer Center Flow Cytometry Core Facility
|